메뉴 건너뛰기




Volumn 30, Issue 9, 2010, Pages 1270-1279

Kava hepatotoxicity: Pathogenetic aspects and prospective considerations

Author keywords

Drug induced liver injury; Hepatotoxicity; Herbal hepatotoxicity; Herbs induced liver injury; Kava; Kava hepatotoxicity; Toxic liver disease; Toxic liver injury

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P450; GLUTATHIONE; GLYCOPROTEIN P; KAVA EXTRACT; PROSTAGLANDIN SYNTHASE; SOLUBILIZER; SOLVENT;

EID: 78349273977     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02308.x     Document Type: Review
Times cited : (65)

References (83)
  • 1
    • 0032553342 scopus 로고    scopus 로고
    • Necrotising hepatitis after taking herbal remedies
    • in German
    • Strahl S, Ehret V, Dahm HH, Maier KP. Necrotising hepatitis after taking herbal remedies. Dtsch Med Wschr 1998; 123: 1410-4. (in German).
    • (1998) Dtsch Med Wschr , vol.123 , pp. 1410-4
    • Strahl, S.1    Ehret, V.2    Dahm, H.H.3    Maier, K.P.4
  • 2
    • 78349263622 scopus 로고    scopus 로고
    • The essential guide to herbal safety
    • a risk-benefit assessment. In: Mills M, Bone K, eds. St Louis, MO): Elsevier Churchill Livingstone
    • Schmidt M, Morgan M, Bone K, McMillan J. Kava: a risk-benefit assessment. In: Mills M, Bone K, eds. The essential guide to herbal safety. St Louis, MO): Elsevier Churchill Livingstone, 2005; 155-221.
    • (2005) Kava , pp. 155-221
    • Schmidt, M.1    Morgan, M.2    Bone, K.3    McMillan, J.4
  • 5
    • 78349299982 scopus 로고    scopus 로고
    • BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn. Federal Institute for Drugs and Medicinal Products in Germany). Rejection of Drug Risks, Step II. As related to: Kava-Kava (Piper methysticum)-containing, and kavain-containing drugs, including homeopathic preparations with a final concentration up to, and including D4. 14 June 2002. Available at, accessed 18 May 2010).
    • BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn. Federal Institute for Drugs and Medicinal Products in Germany). Rejection of Drug Risks, Step II. As related to: Kava-Kava (Piper methysticum)-containing, and kavain-containing drugs, including homeopathic preparations with a final concentration up to, and including D4. 14 June 2002. Available at (accessed 18 May 2010).
  • 8
    • 0036261506 scopus 로고    scopus 로고
    • A systematic review of the safety of kava extract in the treatment of anxiety
    • Stevinson C, Huntley A, Ernst E. A systematic review of the safety of kava extract in the treatment of anxiety. Drug Safety 2002; 25: 251-61.
    • (2002) Drug Safety , vol.25 , pp. 251-61
    • Stevinson, C.1    Huntley, A.2    Ernst, E.3
  • 9
    • 0038249051 scopus 로고    scopus 로고
    • Toxicity of kava pyrones, drug safety and precautions- a case study
    • Schulze J, Raasch W, Siegers CP. Toxicity of kava pyrones, drug safety and precautions- a case study. Phytomedicine 2003; 10 (Suppl. IV): 68-73.
    • (2003) Phytomedicine , vol.10 , Issue.SUPPL. 4 , pp. 68-73
    • Schulze, J.1    Raasch, W.2    Siegers, C.P.3
  • 10
    • 0042338744 scopus 로고    scopus 로고
    • Quality aspects of traditional and industrial kava-extracts
    • Loew D, Franz G. Quality aspects of traditional and industrial kava-extracts. Phytomedicine 2003; 10: 610-2.
    • (2003) Phytomedicine , vol.10 , pp. 610-2
    • Loew, D.1    Franz, G.2
  • 12
    • 0036046724 scopus 로고    scopus 로고
    • Kava extract for treating anxiety (Cochrane Review). In: Cochrane Library, Issue I, 2003 Oxford: Update Software.
    • Pittler MH, Ernst E. Kava extract for treating anxiety (Cochrane Review). In: Cochrane Library, Issue I, 2003 Oxford: Update Software.
    • Pittler, M.H.1    Ernst, E.2
  • 14
    • 34548636945 scopus 로고    scopus 로고
    • A re-evaluation of kava (Piper methysticum)
    • Ernst E. A re-evaluation of kava (Piper methysticum). Br J Clin Pharmacol 2007; 64: 415-7.
    • (2007) Br J Clin Pharmacol , vol.64 , pp. 415-7
    • Ernst, E.1
  • 16
    • 47849130164 scopus 로고    scopus 로고
    • Assessments of the risk of hepatotoxicity with kava products
    • World Health Organization., Geneva, Switzerland: WHO Document Production Services
    • World Health Organization. Assessments of the risk of hepatotoxicity with kava products. Geneva, Switzerland: WHO Document Production Services, 2007.
    • (2007)
  • 17
    • 55249125241 scopus 로고    scopus 로고
    • Kava hepatotoxicity
    • New Zeal Med J, Available at, accessed 18 May 2010)
    • Teschke R, Schwarzenboeck A, Akinci A. Kava hepatotoxicity: a European view. New Zeal Med J 2008; 121: 1283 Available at (accessed 18 May 2010).
    • (2008) a European view , vol.121 , pp. 1283
    • Teschke, R.1    Schwarzenboeck, A.2    Akinci, A.3
  • 19
    • 78349260262 scopus 로고    scopus 로고
    • Kava hepatotoxicity - a clinical review
    • Teschke R. Kava hepatotoxicity - a clinical review. Ann Hepatol 2010; 9: in press.
    • (2010) Ann Hepatol , vol.9
    • Teschke, R.1
  • 21
    • 0003553395 scopus 로고    scopus 로고
    • Kava, the Pacific elixir
    • New Haven: Yale University Press
    • Lebot V, Merlin M, Lindstrom L. Kava, the Pacific elixir. New Haven: Yale University Press, 1997.
    • (1997)
    • Lebot, V.1    Merlin, M.2    Lindstrom, L.3
  • 22
    • 0026728263 scopus 로고
    • Kava
    • J Ethnopharmacol
    • Singh YH. Kava: an overview. J Ethnopharmacol 1992; 37: 13-45.
    • (1992) an overview , vol.37 , pp. 13-45
    • Singh, Y.H.1
  • 23
    • 38849103386 scopus 로고    scopus 로고
    • The quality of kava consumed in the South Pacific
    • Lebot V. The quality of kava consumed in the South Pacific. Herbal Gram 2006; 71: 34-7.
    • (2006) Herbal Gram , vol.71 , pp. 34-7
    • Lebot, V.1
  • 24
    • 23044503814 scopus 로고    scopus 로고
    • Potential for interaction of kava and St. John's wort with drugs
    • Singh YH. Potential for interaction of kava and St. John's wort with drugs. J Ethnopharmacol 2005; 100: 108-13.
    • (2005) J Ethnopharmacol , vol.100 , pp. 108-13
    • Singh, Y.H.1
  • 25
    • 38849087754 scopus 로고    scopus 로고
    • Quality criteria for kava
    • Schmidt M. Quality criteria for kava. HerbalGram 2007; 73: 45-9.
    • (2007) HerbalGram , vol.73 , pp. 45-9
    • Schmidt, M.1
  • 27
    • 56549100205 scopus 로고    scopus 로고
    • Causality assessment in hepatotoxicity by drugs and dietary supplements
    • Teschke R, Schwarzenboeck A, Hennermann KH. Causality assessment in hepatotoxicity by drugs and dietary supplements. Brit J Clin Pharmacol 2008; 66: 758-66.
    • (2008) Brit J Clin Pharmacol , vol.66 , pp. 758-66
    • Teschke, R.1    Schwarzenboeck, A.2    Hennermann, K.H.3
  • 28
  • 30
    • 77949379937 scopus 로고    scopus 로고
    • Black cohosh and suspected hepatotoxicity - inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm
    • Menopause
    • Teschke R. Black cohosh and suspected hepatotoxicity - inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm: a critical review. Menopause 2010; 17: 426-40.
    • (2010) a critical review , vol.17 , pp. 426-40
    • Teschke, R.1
  • 31
    • 77957716014 scopus 로고    scopus 로고
    • Letter to the editor., Menopause, DOI: DOI: 10.1097/gme.0b013e3181e32349. [Epub ahead of print].
    • Teschke R. Letter to the editor. Menopause 2010. DOI: DOI: 10.1097/gme.0b013e3181e32349. [Epub ahead of print].
    • (2010)
    • Teschke, R.1
  • 32
    • 16644400366 scopus 로고    scopus 로고
    • Kava update
    • New Zeal Med J, Available at, accessed 18 May 2010).
    • Ernst E. Kava update: a European perspective. New Zeal Med J 2004; 117: 1205. Available at (accessed 18 May 2010).
    • (2004) a European perspective , vol.117 , pp. 1205
    • Ernst, E.1
  • 35
  • 36
    • 33745928735 scopus 로고    scopus 로고
    • A meta-analysis of the association between adherence to drug therapy and mortality
    • Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. Br Med J 2006; 333: 15-8.
    • (2006) Br Med J , vol.333 , pp. 15-8
    • Simpson, S.H.1    Eurich, D.T.2    Majumdar, S.R.3
  • 39
    • 0345564969 scopus 로고    scopus 로고
    • Liver function test abnormalities in users of aqueous kava extracts
    • Clough AR, Bailie RS, Currie B. Liver function test abnormalities in users of aqueous kava extracts. J Toxicol/Clin Toxicol 2003; 41: 821-9.
    • (2003) J Toxicol/Clin Toxicol , vol.41 , pp. 821-9
    • Clough, A.R.1    Bailie, R.S.2    Currie, B.3
  • 40
    • 0043263837 scopus 로고    scopus 로고
    • Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia
    • Russmann S, Barguil Y, Cabalion P, et al. Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia. Eur J Gastroenterol Hepatol 2003; 15: 1033-6.
    • (2003) Eur J Gastroenterol Hepatol , vol.15 , pp. 1033-6
    • Russmann, S.1    Barguil, Y.2    Cabalion, P.3
  • 42
    • 2442680397 scopus 로고    scopus 로고
    • Safety and efficacy of herbal sedatives in cancer care
    • Block KI, Gyllenhaal C, Mead MN. Safety and efficacy of herbal sedatives in cancer care. Integr Cancer Ther 2004; 3: 128-48.
    • (2004) Integr Cancer Ther , vol.3 , pp. 128-48
    • Block, K.I.1    Gyllenhaal, C.2    Mead, M.N.3
  • 43
    • 35248816024 scopus 로고    scopus 로고
    • The controvertible role of kava (Piper methysticum G. Forster) an anxiolytic herb, on toxic hepatitis
    • Amorim MFD, Diniz MFFM, Araújo MST, et al. The controvertible role of kava (Piper methysticum G. Forster) an anxiolytic herb, on toxic hepatitis. Rev Bras Farmacogn 2007; 17: 448-54.
    • (2007) Rev Bras Farmacogn , vol.17 , pp. 448-54
    • Amorim, M.F.D.1    Diniz, M.F.F.M.2    Araújo, M.S.T.3
  • 44
    • 21744457082 scopus 로고    scopus 로고
    • Safety review of kava (Piper methysicum) by the Natural Standard Research Collaboration
    • Ulbricht C, Basch E, Boon H, et al. Safety review of kava (Piper methysicum) by the Natural Standard Research Collaboration. Exp Opin Drug Saf 2005; 4: 779-94.
    • (2005) Exp Opin Drug Saf , vol.4 , pp. 779-94
    • Ulbricht, C.1    Basch, E.2    Boon, H.3
  • 45
    • 37349091412 scopus 로고    scopus 로고
    • Hepatocellular toxicity of kava leaf and root extracts
    • Lüde S, Török M, Dieterle S, et al. Hepatocellular toxicity of kava leaf and root extracts. Phytomedicine 2008; 15: 120-13.
    • (2008) Phytomedicine , vol.15 , pp. 120-13
    • Lüde, S.1    Török, M.2    Dieterle, S.3
  • 46
    • 40549094283 scopus 로고    scopus 로고
    • Efficacy of extracting solvents to chemical compounds of kava (Piper methysticum) root
    • Xuan TD, Fukuta AA, Wie AC, et al. Efficacy of extracting solvents to chemical compounds of kava (Piper methysticum) root. J Nat Med 2008; 62: 188-94.
    • (2008) J Nat Med , vol.62 , pp. 188-94
    • Xuan, T.D.1    Fukuta, A.A.2    Wie, A.C.3
  • 47
    • 34247135372 scopus 로고    scopus 로고
    • Kava feeding in rats does not cause liver injury nor enhance galactosamine-induced hepatitis
    • DiSilvestro RA, Zhang W, DiSilvestro DJ. Kava feeding in rats does not cause liver injury nor enhance galactosamine-induced hepatitis. Food Chem Toxicol 2007; 45: 1293-300.
    • (2007) Food Chem Toxicol , vol.45 , pp. 1293-300
    • DiSilvestro, R.A.1    Zhang, W.2    DiSilvestro, D.J.3
  • 48
    • 0037396162 scopus 로고    scopus 로고
    • Are kavalactones the hepatotoxic principle of kava extracts? The pitfalls of the glutathione theory. Letter to the Editor
    • Schmidt M. Are kavalactones the hepatotoxic principle of kava extracts? The pitfalls of the glutathione theory. Letter to the Editor. J Altern Complement Med 2003; 9: 183-8.
    • (2003) J Altern Complement Med , vol.9 , pp. 183-8
    • Schmidt, M.1
  • 50
    • 0036183953 scopus 로고    scopus 로고
    • Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots
    • Wu D, Yu L, Nair MG, DeWitt DL, Ramsewak RS. Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots. Phytomedicine 2002; 9: 41-7.
    • (2002) Phytomedicine , vol.9 , pp. 41-7
    • Wu, D.1    Yu, L.2    Nair, M.G.3    DeWitt, D.L.4    Ramsewak, R.S.5
  • 51
    • 78349252239 scopus 로고    scopus 로고
    • Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro
    • Weiss J, Sauer A, Frank A, Unger M. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro. Drug Metab Dispos 2006; 34: 203-7.
    • (2006) Drug Metab Dispos , vol.34 , pp. 203-7
    • Weiss, J.1    Sauer, A.2    Frank, A.3    Unger, M.4
  • 52
    • 0036842023 scopus 로고    scopus 로고
    • Inhibition of human cytochrome P450 activities by kava extract and kavalactones
    • Mathews JM, Etheridge AS, Black SR. Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metab Dispos 2002; 30: 1153-7.
    • (2002) Drug Metab Dispos , vol.30 , pp. 1153-7
    • Mathews, J.M.1    Etheridge, A.S.2    Black, S.R.3
  • 53
    • 2342475708 scopus 로고    scopus 로고
    • Kava does not display metabolic toxicity in a homogeneous cellular assay
    • Zou L, Harkey MR, Henderson GL, Dike LE. Kava does not display metabolic toxicity in a homogeneous cellular assay. Planta Med 2004; 70: 289-92.
    • (2004) Planta Med , vol.70 , pp. 289-92
    • Zou, L.1    Harkey, M.R.2    Henderson, G.L.3    Dike, L.E.4
  • 54
    • 19144363905 scopus 로고    scopus 로고
    • In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4 phenotypes
    • Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4 phenotypes. Clin Pharmacol Ther 2005; 77: 415-26.
    • (2005) Clin Pharmacol Ther , vol.77 , pp. 415-26
    • Gurley, B.J.1    Gardner, S.F.2    Hubbard, M.A.3
  • 55
    • 3242677212 scopus 로고    scopus 로고
    • Pharmacokinetic and pharmacodynamic drug interactions with kava (Piper methysticum Forst. f.)
    • Anke J, Ramzan I. Pharmacokinetic and pharmacodynamic drug interactions with kava (Piper methysticum Forst. f.). J Ethnopharmacol 2004; 93: 153-60.
    • (2004) J Ethnopharmacol , vol.93 , pp. 153-60
    • Anke, J.1    Ramzan, I.2
  • 56
    • 22844441147 scopus 로고    scopus 로고
    • Herb-drug interactions. A literature review
    • Hu Z, Yang X, Ho PCL, et al. Herb-drug interactions. A literature review. Drugs 2005; 65: 1239-82.
    • (2005) Drugs , vol.65 , pp. 1239-82
    • Hu, Z.1    Yang, X.2    Ho, P.C.L.3
  • 57
    • 58149512737 scopus 로고    scopus 로고
    • Analysis of gene expression changes of drug metabolizing enzymes in the livers of F344 rats following oral treatment with kava extract
    • Guo L, Li Q, Xia Q, et al. Analysis of gene expression changes of drug metabolizing enzymes in the livers of F344 rats following oral treatment with kava extract. Food Chem Toxicol 2009; 47: 433-42.
    • (2009) Food Chem Toxicol , vol.47 , pp. 433-42
    • Guo, L.1    Li, Q.2    Xia, Q.3
  • 59
    • 74649085160 scopus 로고    scopus 로고
    • Gen expression profiling in male B6C3F1 mouse livers exposed to kava identifies - Changes in drug-metabolizing genes and potential mechanism linked to kava toxicity
    • Guo L, Shi Q, Dial S, et al. Gen expression profiling in male B6C3F1 mouse livers exposed to kava identifies - Changes in drug-metabolizing genes and potential mechanism linked to kava toxicity. Food Chem Toxicol 2010; 48: 6886-696.
    • (2010) Food Chem Toxicol , vol.48 , pp. 6886-696
    • Guo, L.1    Shi, Q.2    Dial, S.3
  • 60
    • 77951613085 scopus 로고    scopus 로고
    • Role of ethanol in kava hepatotoxicity
    • Li XZ, Ramzan I. Role of ethanol in kava hepatotoxicity. Phytother Res 2010; 24: 475-80.
    • (2010) Phytother Res , vol.24 , pp. 475-80
    • Li, X.Z.1    Ramzan, I.2
  • 61
  • 62
    • 38849086101 scopus 로고    scopus 로고
    • Is the alkaloid pipermethystine connected with the claimed liver toxicity of kava products?
    • Lechtenberg M, Quandt B, Schmidt M, Nahrstedt A. Is the alkaloid pipermethystine connected with the claimed liver toxicity of kava products? Pharmazie 2008; 63: 71-4.
    • (2008) Pharmazie , vol.63 , pp. 71-4
    • Lechtenberg, M.1    Quandt, B.2    Schmidt, M.3    Nahrstedt, A.4
  • 63
    • 34347232391 scopus 로고    scopus 로고
    • Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats
    • Lim ST, Dragull K, Tang CS, et al. Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats. Toxicol Sci 2007; 97: 214-21.
    • (2007) Toxicol Sci , vol.97 , pp. 214-21
    • Lim, S.T.1    Dragull, K.2    Tang, C.S.3
  • 64
    • 2442710270 scopus 로고    scopus 로고
    • In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones
    • Nerurkar PV, Dragull K, Tang CS. In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones. Toxicol Sci 2004; 79: 106-11.
    • (2004) Toxicol Sci , vol.79 , pp. 106-11
    • Nerurkar, P.V.1    Dragull, K.2    Tang, C.S.3
  • 65
    • 33646500546 scopus 로고    scopus 로고
    • In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum)
    • Jhoo JW, Freeman JP, Heinze TM, et al. In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum). J Agric Food Chem 2006; 54: 3157-62.
    • (2006) J Agric Food Chem , vol.54 , pp. 3157-62
    • Jhoo, J.W.1    Freeman, J.P.2    Heinze, T.M.3
  • 67
    • 0037650196 scopus 로고    scopus 로고
    • Fatal fulminant hepatic failure induced by a natural therapy containing kava
    • Gow PJ, Connelly NJ, Hill RL, Crowley P, Angus PW. Fatal fulminant hepatic failure induced by a natural therapy containing kava. Med J Aust 2003; 178: 442-4.
    • (2003) Med J Aust , vol.178 , pp. 442-4
    • Gow, P.J.1    Connelly, N.J.2    Hill, R.L.3    Crowley, P.4    Angus, P.W.5
  • 69
    • 78349234451 scopus 로고    scopus 로고
    • SPC Report. Pacific kava: a producer's guide. ISBN 982-203-810-0
    • Secretariat of the Pacific Community., Suva, Fiji Islands: Secretariat of the Pacific Community,
    • Secretariat of the Pacific Community. SPC Report. Pacific kava: a producer's guide. ISBN 982-203-810-0. Suva, Fiji Islands: Secretariat of the Pacific Community, 2001.
    • (2001)
  • 70
    • 78349247696 scopus 로고    scopus 로고
    • BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn. Federal Institute for Drugs and Medicinal Products in Germany), 12 May 2005. Available at, accessed 18 May 2010).
    • BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn. Federal Institute for Drugs and Medicinal Products in Germany), 12 May 2005. Available at (accessed 18 May 2010).
  • 71
    • 78349237573 scopus 로고    scopus 로고
    • Kava. A human health risk assessment. Technical report Series No. 30
    • Food standards Australia and New Zealand, Food standards Australia and New Zealand, Available at, accessed 18 May 2010).
    • Food standards Australia and New Zealand Kava. A human health risk assessment. Technical report Series No. 30, 2005. Food standards Australia and New Zealand Available at (accessed 18 May 2010).
    • (2005)
  • 72
    • 34248545938 scopus 로고    scopus 로고
    • Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii
    • Brown AC, Onopa JO, Holck P, et al. Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii. Clin Toxicol 2007; 45: 549-56.
    • (2007) Clin Toxicol , vol.45 , pp. 549-56
    • Brown, A.C.1    Onopa, J.O.2    Holck, P.3
  • 73
    • 78349249204 scopus 로고    scopus 로고
    • Commission E of BGA/BfArM, 1990. Monographie Piperis methystici rhizoma (Kava-Kava-Wurzelstock). Bundesanzeiger Nr. 101; dated 1 June 1990.
    • Commission E of BGA/BfArM, 1990. Monographie Piperis methystici rhizoma (Kava-Kava-Wurzelstock). Bundesanzeiger Nr. 101; dated 1 June 1990.
  • 74
    • 78349253610 scopus 로고    scopus 로고
    • Deutscher Arzneimittel-Codex (DAC). Kava-Kava-Wurzelstock: Piperis methystici rhizoma. Official monograph, 1998, Govi-Verlag, Eschborn (Germany).
    • Deutscher Arzneimittel-Codex (DAC). Kava-Kava-Wurzelstock: Piperis methystici rhizoma. Official monograph, 1998, Govi-Verlag, Eschborn (Germany).
  • 77
    • 0022851547 scopus 로고
    • Hepatic microsomal ethanol-oxidizing system (MEOS)
    • Alcoholism. Clin Exp Res
    • Teschke R, Gellert J. Hepatic microsomal ethanol-oxidizing system (MEOS): metabolic aspects and clinical implications. Alcoholism. Clin Exp Res 1986; 10 (Suppl.): 20-32.
    • (1986) metabolic aspects and clinical implications , vol.10 , Issue.SUPPL. , pp. 20-32
    • Teschke, R.1    Gellert, J.2
  • 80
    • 0037973477 scopus 로고    scopus 로고
    • Hepatitis induced by kava (Piper methysticum rhizoma)
    • Stickel F, Baumüller HM, Seitz K, et al. Hepatitis induced by kava (Piper methysticum rhizoma). J Hepatol 2003; 39: 62-7.
    • (2003) J Hepatol , vol.39 , pp. 62-7
    • Stickel, F.1    Baumüller, H.M.2    Seitz, K.3
  • 81
    • 0004039221 scopus 로고    scopus 로고
    • Hepatotoxicity
    • Philadelphia: Lippincott Williams & Wilkins
    • Zimmerman HJ. Hepatotoxicity. Philadelphia: Lippincott Williams & Wilkins, 1999.
    • (1999)
    • Zimmerman, H.J.1
  • 83
    • 47849099259 scopus 로고    scopus 로고
    • Quantification of kavalactones and determination of kava (Piper methysticum) chemotypes using near-infrared reflectance spectroscopy for quality control in Vanuatu
    • Lasme P, Davrieux F, Montet D, Lebot V. Quantification of kavalactones and determination of kava (Piper methysticum) chemotypes using near-infrared reflectance spectroscopy for quality control in Vanuatu. J Agric Food Chem 2008; 56: 4976-81.
    • (2008) J Agric Food Chem , vol.56 , pp. 4976-81
    • Lasme, P.1    Davrieux, F.2    Montet, D.3    Lebot, V.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.